World’s first comparative study shows safety of single-port robotic thymectomy

Bris­tol My­ers Squibb, John­son & John­son and the US gov­ern­ment agreed that the two com­pa­nies can con­sol­i­date their briefs to­geth­er in their cas­es against the

Ra­dio­net­ics On­col­o­gy is in the midst of a fundrais­ing dri­ve worth $68.7 mil­lion, with the Cal­i­for­nia-based com­pa­ny hav­ing raised $54.2 mil­lion so far, per an